-1753896303755.webp&w=3840&q=75)
2025 NOSCM | How To Sequence Therapy in Patients with Relapsed/Refractory Multiple Myeloma
Overview
Dr. Jonathan Kaufman discussed treatment sequencing in relapsed/refractory multiple myeloma, noting NCCN guideline gaps and the value of triplet regimens. He highlighted CAR T therapies (Cilta-cel, Ide-cel), emphasized bridging therapy, and addressed toxicity management, especially infections.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Jonathan L. Kaufman, MD
Date of Release
July 30th, 2025
-1753896225110.webp&w=3840&q=75)
